Search Within

Maura N Dickler

Formats
  1. Meeting Abstract (141)
  2. Journal Article (115)
  3. Book Section (5)
  4. Conference Paper (1)
  5. Review (1)
Groups
  1. Department of Medicine (169)
  2. Solid Tumor Oncology Division (163)
  3. Breast Medicine Service (155)
  4. Survivorship Research (152)
  5. Epidemiology and Biostatistics (105)
  6. Population Sciences Research Program (89)

More Groups

People
  1. Clifford Hudis (102)
  2. Larry Norton (64)
  3. Shari Goldfarb (51)
  4. Chau Dang (39)
  5. Sujata Patil (35)
  6. Tiffany Traina (34)

More People

Years
  1. 2023 (1)
  2. 2021 (1)
  3. 2020 (6)
  4. 2019 (4)
  5. 2018 (20)
  6. 2017 (29)

More Years

Publications
  1. Journal of Clinical Oncology (69)
  2. Cancer Research (41)
  3. Breast Cancer Research and Treatment (18)
  4. Clinical Cancer Research (14)
  5. Annals of Oncology (10)
  6. Journal of Sexual Medicine (7)

More Publications

Publishers
  1. American Society of Clinical Oncology (70)
  2. American Association for Cancer Research (57)
  3. Springer (26)
  4. Elsevier Inc. (18)
  5. Oxford University Press (18)
  6. Elsevier Science, Inc. (7)

More Publishers

Results (263)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Comparison of FDG-PET/CT with contrast enhanced CT for prediction of progression-free and disease-specific survival in stage IV breast cancer patients: A retrospective analysis
    Meeting Abstract

    Riedl, C.; Pinker, K.; Ong, L.; Jochelson, M.; Ulaner, G.; Mcarthur, H.; Dickler, M.; Weber, W.
    Journal of Nuclear Medicine (2015)

    Fulltext@MSK | Save
  • How does the number of lesions analyzed impact response assessment with PERCIST in breast cancer?
    Meeting Abstract

    Pinker, K.; Riedl, C.; Ong, L.; Jochelson, M.; Ulaner, G.; Dickler, M.; Weber, W.
    Journal of Nuclear Medicine (2015)

    Fulltext@MSK | Save
  • A phase Ib study of abemaciclib with therapies for metastatic breast cancer
    Meeting Abstract

    Tolaney, S. M.; Beeram, M.; Beck, J. T.; Conlin, A. K.; Dees, E. C.; Dickler, M. N.; Helsten, T. L.; Conkling, P. R.; Edenfield, W. J.; Richards, D. A.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Oncotype DX in BRCA-associated vs. sporadic breast cancers: Differences based on germline mutation status and potential implications for adjuvant systemic therapy (AST)
    Meeting Abstract

    Shah, P. D.; Patil, S.; Dickler, M. N.; Offit, K.; Hudis, C. A.; Robson, M. E.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase I study of LJM716, BYL719, and trastuzumab in patients (pts) with HER2-amplified (HER2+) metastatic breast cancer (MBC)
    Meeting Abstract

    Shah, P. D.; Chandarlapaty, S.; Dickler, M. N.; Ulaner, G.; Zamora, S. J.; Sterlin, V.; Iasonos, A.; Coughlin, C. M.; Morozov, A.; Ero, J.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • FDG-PET/CT versus contrast enhanced CT for prediction of progression-free and disease-specific survival in stage IV breast cancer patients
    Meeting Abstract

    Riedl, C.; Pinker, K.; Ong, L.; Jochelson, M. S.; Ulaner, G.; Mcarthur, H. L.; Dickler, M. N.; Weber, W.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Is response classification with PERCIST in stage IV breast cancer influenced by the number of lesions assessed?
    Meeting Abstract

    Pinker, K.; Riedl, C.; Ong, L.; Jochelson, M. S.; Ulaner, G.; Dickler, M. N.; Weber, W.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • The impact of adjuvant breast cancer (BC) chemotherapy on ovarian reserve and menses
    Meeting Abstract

    Goldfarb, S. B.; Bedoschi, G.; Grunblatt, E.; Goswami, S.; Cigler, T.; Quistorff, J.; Pacheco, F.; Stobezki, R.; Robson, M. E.; Moy, F.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase III trial evaluating the addition of bevacizumab to letrozole as first-line endocrine therapy for treatment of hormone-receptor positive advanced breast cancer: CALGB 40503 (Alliance)
    Meeting Abstract

    Dickler, M. N.; Barry, W. T.; Cirrincione, C. T.; Ellis, M. J.; Moynahan, M. E.; Innocenti, F.; Hurria, A.; Rugo, H. S.; Lake, D.; Hahn, O. M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase I, open-label study evaluating the safety and tolerability of LJM716, BYL719 and trastuzumab in patients with metastatic HER2+ breast cancer
    Meeting Abstract

    Shah, P. D.; Chandarlapaty, S.; Ulaner, G.; Zamora, S.; Sterlin, V.; Iasonos, A.; Dickler, M. N.; Moynahan, M. E.; Hudis, C. A.; Baselga, J.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save